Page last updated: 2024-11-05

zonisamide and Diabetes Mellitus, Type 2

zonisamide has been researched along with Diabetes Mellitus, Type 2 in 2 studies

Zonisamide: A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.
zonisamide : A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.

Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Tian, JH1
Wu, Q1
He, YX1
Shen, QY1
Rekep, M1
Zhang, GP1
Luo, JD1
Xue, Q1
Liu, YH1
Aylwin, S1
Al-Zaman, Y1

Reviews

1 review available for zonisamide and Diabetes Mellitus, Type 2

ArticleYear
Emerging concepts in the medical and surgical treatment of obesity.
    Frontiers of hormone research, 2008, Volume: 36

    Topics: Adipose Tissue; Amyloid; Anticonvulsants; Antidepressive Agents; Anxiety; Appetite Regulation; Baria

2008

Other Studies

1 other study available for zonisamide and Diabetes Mellitus, Type 2

ArticleYear
Zonisamide, an antiepileptic drug, alleviates diabetic cardiomyopathy by inhibiting endoplasmic reticulum stress.
    Acta pharmacologica Sinica, 2021, Volume: 42, Issue:3

    Topics: Animals; Anticonvulsants; Apoptosis; Blood Glucose; Body Weight; Cardiomegaly; Diabetes Mellitus, Ty

2021